The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer (Q67542391)
Jump to navigation
Jump to search
scientific article published on 01 September 1992
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer |
scientific article published on 01 September 1992 |
Statements
The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer (English)
M J Reed
A Christodoulides
R Koistinen
M Seppälä
J D Teale
M W Ghilchik
1 September 1992